• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

TapImmune Inc

+ Add to Watchlist

TPIV:US

0.2850 USD 0.0650 18.57%

As of 11:22:17 ET on 10/21/2014.

Snapshot for TapImmune Inc (TPIV)

Open: 0.3500 Day's Range: 0.2850 - 0.3500 Volume: 40,672
Previous Close: 0.3500 52wk Range: 0.2850 - 7.0000 1-Yr Rtn: -73.91%

Stock Chart for TPIV

No chart data available.
  • TPIV:US 0.2850
  • 1D
  • 1M
  • 1Y
0.3500
Interactive TPIV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TPIV

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -3.7831
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 6.49
Shares Outstanding (M) 19.08
30 Day Average Volume 91,488
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TPIV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TPIV

TapImmune, Inc. is a biotechnology company that discovers and develops immunotherapeutics aimed at the treatment and eradication of cancer. The Company also develops therapies for infectious diseases, autoimmune disorders, and transplant tissue rejection.

Glynn WilsonChairman/CEO/CFO/SecretaryMark ReddishVP:Product Development
Thad MorrisInvestor Relations
More Company Profile & Key Executives for TPIV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil